PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1100 participants.
Also called NCT03559114
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 1,100 participants
- Registry
-
NCT03559114
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Canada
- Registry status
- Recruiting
Technical summary
Registry record NCT03559114. Randomized; triple masking; primary purpose prevention. Start 2018-07-19 (actual); primary completion 2026-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST)
- Acronym
- PROTEST
- Condition
- Traumatic Brain Injury
- Intervention (Drug)
- Dalteparin
- Intervention (Drug)
- Saline
- Lead sponsor
- Sunnybrook Health Sciences Centre
- Collaborator
- Sunnybrook Research Institute
Record details
- Record id
cardio:ct-nct03559114- Content hash
b52ba0e0a6bac61efb32bfaa05c929d7febf450a9ae10575f4b0f8f3b8027fc3